Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMCOpen access

TREM2 regulates obesity-induced insulin resistance via adipose tissue remodeling in mice of high-fat feeding

Liu C., Li P., Li H., Wang S., Ding L., Wang H.

Animal Study on Type 2 Diabetes, Chronic Inflammation, published in J Transl Med (2019) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
J Transl Med (2019)
Reported sample size
—
Source database
Europe PMC
PMID
31477129
PMCID
PMC6720981
DOI
10.1186/s12967-019-2050-9
Citations
60

Abstract (original English)

Background Adipose tissue remodeling plays a significant role in obesity-induced insulin resistance. Published studies reported that level of trigger receptor expressed on myeloid cells 2 (TREM2) in adipose tissue is up-regulated in animal models of obesity. This study aims to investigate whether TREM2 regulates obesity-induced insulin resistance via modulating adipose tissue remodeling in mice of high-fat diet (HFD). Methods Wild-type (WT) and TREM2 -/- mice were both fed with a controlled-fat diet (CFD) or HFD for 12 weeks and studied for obesity and insulin resistance. Meanwhile, epididymal adipose tissue (EAT) was examined for morphological and pathological changes to determine adipose tissue remodeling. After that, adipocyte-derived MCP-1 was measured in adipocytes, adipose tissue and circulation. Next, inflammatory cytokines were determined in adipose tissue macrophages (ATM). At last, livers were analyzed for hepatic steatosis. Results TREM2 -/- mice on HFD had increased obesity and insulin resistance compared with WT counterparts. Adipose tissue from TREM2 -/- mice exhibited reduced mass but greater adipocyte hypertrophy and increased adipocyte death. Besides, adipocyte-derived MCP-1 was down-regulated in TREM2 -/- mice, and circulating MCP-1 level was lower than that of WT mice. Furthermore, TREM2 -/- mice displayed reduced infiltration of F4/80 + CD11c + macrophages i

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Adipose TissueAdipocytesMacrophagesAnimalsMice, Inbred C57BLLiver CirrhosisInsulin ResistanceObesityHypertrophyInflammation

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research